Skip to content

PHARMA-BIO SERV, INC.: 10-Q filed 2012-09-14

What PHARMA-BIO SERV, INC. reported in its quarterly report filed 2012-09-14 (fiscal Q3 2012): 32 published measures, 106 facts as tagged in accession 0001354488-12-004893.

This filing

Form
10-Q (quarterly report)
Filed
2012-09-14
Fiscal period
fiscal Q3 2012
Accession
0001354488-12-004893 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All PHARMA-BIO SERV, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2012-07-3113,919,727USD
At 2011-10-3110,852,199USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2012-07-312,164,624USD
At 2011-10-312,615,874USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2012-07-3111,755,103USD
At 2011-10-318,236,325USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2012-07-315,027,185USD
At 2012-04-303,975,522USD
At 2011-10-314,316,725USD
At 2011-07-313,588,049USD
At 2011-04-302,552,989USD
At 2010-10-312,317,168USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2012-05-01 to 2012-07-311,275,898USD92
2011-11-01 to 2012-07-313,610,441USD274
2011-05-01 to 2011-07-311,498,602USD92
2010-11-01 to 2011-07-312,334,554USD273

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2012-05-01 to 2012-07-311,143,060USD92
2011-11-01 to 2012-07-31937,308USD274
2011-05-01 to 2011-07-311,054,280USD92
2010-11-01 to 2011-07-311,347,425USD273

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2012-05-01 to 2012-07-3159,983USD92
2011-11-01 to 2012-07-31155,822USD274
2011-05-01 to 2011-07-312,549USD92
2010-11-01 to 2011-07-3168,764USD273

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2012-05-01 to 2012-07-31-7,869USD92
2011-11-01 to 2012-07-31-23,107USD274
2011-05-01 to 2011-07-31-7,976USD92
2010-11-01 to 2011-07-31-17,791USD273

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2012-05-01 to 2012-07-31-59,983USD92
2011-11-01 to 2012-07-31-155,141USD274
2011-05-01 to 2011-07-31-2,549USD92
2010-11-01 to 2011-07-31-68,764USD273

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2012-07-3111,210,150USD
At 2011-10-317,599,708USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2012-05-01 to 2012-07-3120,758,695shares92
2011-11-01 to 2012-07-3120,758,695shares274
2011-05-01 to 2011-07-3120,754,954shares92
2010-11-01 to 2011-07-3120,752,475shares273

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2012-05-01 to 2012-07-3122,980,475shares92
2011-11-01 to 2012-07-3122,877,147shares274
2011-05-01 to 2011-07-3122,515,391shares92
2010-11-01 to 2011-07-3122,500,875shares273

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2012-05-01 to 2012-07-310.061USD/shares92
2011-11-01 to 2012-07-310.174USD/shares274
2011-05-01 to 2011-07-310.072USD/shares92
2010-11-01 to 2011-07-310.112USD/shares273

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2012-05-01 to 2012-07-310.056USD/shares92
2011-11-01 to 2012-07-310.158USD/shares274
2011-05-01 to 2011-07-310.067USD/shares92
2010-11-01 to 2011-07-310.104USD/shares273

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2012-05-01 to 2012-07-31297,173USD92
2011-11-01 to 2012-07-31752,231USD274
2011-05-01 to 2011-07-31-328,268USD92
2010-11-01 to 2011-07-3195,840USD273

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2012-07-311,137,874USD
At 2011-10-311,216,111USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2012-05-01 to 2012-07-312,166USD92
2011-11-01 to 2012-07-3121,498USD274
2011-05-01 to 2011-07-312,166USD92
2010-11-01 to 2011-07-316,498USD273

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2012-05-01 to 2012-07-311,572,666USD92
2011-11-01 to 2012-07-314,360,424USD274
2011-05-01 to 2011-07-311,167,579USD92
2010-11-01 to 2011-07-312,421,861USD273

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2012-07-3112,753,479USD
At 2011-10-319,607,782USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2012-05-01 to 2012-07-311,915USD92
2011-11-01 to 2012-07-316,243USD274
2011-05-01 to 2011-07-312,575USD92
2010-11-01 to 2011-07-315,916USD273

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2012-07-312,097,512USD
At 2011-10-312,523,637USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2012-07-317,185,615USD
At 2011-10-314,864,616USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2012-05-01 to 2012-07-312,598,826USD92
2011-11-01 to 2012-07-317,241,614USD274
2011-05-01 to 2011-07-311,999,504USD92
2010-11-01 to 2011-07-314,720,512USD273

Selling, general and administrative expense

Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.

PeriodValueUnitDays
2012-05-01 to 2012-07-311,026,160USD92
2011-11-01 to 2012-07-312,881,190USD274
2011-05-01 to 2011-07-31831,925USD92
2010-11-01 to 2011-07-312,298,651USD273

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2012-07-3120,758,695shares
At 2011-10-3120,758,695shares

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

PeriodValueUnitDays
At 2012-07-31-133,171USD
At 2011-10-31-20,009USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2012-07-311,481,735USD
At 2011-10-311,250,748USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2012-07-3128,374USD
At 2011-10-3128,306USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2012-05-01 to 2012-07-311,573,071USD92
2011-11-01 to 2012-07-314,362,672USD274
2011-05-01 to 2011-07-311,170,334USD92
2010-11-01 to 2011-07-312,430,394USD273

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

PeriodValueUnitDays
2012-05-01 to 2012-07-3180,268USD92
2011-11-01 to 2012-07-31231,969USD274
2011-05-01 to 2011-07-3177,895USD92
2010-11-01 to 2011-07-31226,736USD273

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2012-05-01 to 2012-07-31405USD92
2011-11-01 to 2012-07-312,248USD274
2011-05-01 to 2011-07-312,755USD92
2010-11-01 to 2011-07-318,533USD273

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2012-05-01 to 2012-07-31-292,059USD92
2011-11-01 to 2012-07-31-2,414,997USD274
2011-05-01 to 2011-07-31-145,283USD92
2010-11-01 to 2011-07-31-1,566,249USD273

Inspect the source

Entity
PHARMA-BIO SERV, INC. / CIK 0001304161
Captured
2026-09-19T11:17:27.241Z
SEC response SHA-256
bc9f33e072a9daa74aa0e8c41fbfef83d107920bc25647db80386f28787f2d49

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001304161.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))